201 related articles for article (PubMed ID: 33934137)
1. Therapeutic Efficacy of Bacteriophage Therapy to Treat Carbapenem Resistant Klebsiella Pneumoniae in Mouse Model.
Dhungana G; Regmi M; Paudel P; Parajuli A; Upadhyay E; Gyawali I; Upreti H; Nepal R; Pradhan P; Malla R
J Nepal Health Res Counc; 2021 Apr; 19(1):76-82. PubMed ID: 33934137
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and Pharmacodynamics of a Novel Virulent Klebsiella Phage Kp_Pokalde_002 in a Mouse Model.
Dhungana G; Nepal R; Regmi M; Malla R
Front Cell Infect Microbiol; 2021; 11():684704. PubMed ID: 34485172
[TBL] [Abstract][Full Text] [Related]
3. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model.
Anand T; Virmani N; Kumar S; Mohanty AK; Pavulraj S; Bera BC; Vaid RK; Ahlawat U; Tripathi BN
J Glob Antimicrob Resist; 2020 Jun; 21():34-41. PubMed ID: 31604128
[TBL] [Abstract][Full Text] [Related]
4. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant
Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J
Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713
[No Abstract] [Full Text] [Related]
5. Characterization of Novel
Mulani MS; Kumkar SN; Pardesi KR
Microbiol Spectr; 2022 Dec; 10(6):e0199422. PubMed ID: 36374021
[TBL] [Abstract][Full Text] [Related]
6. Characterization and genome analysis of Klebsiella phage P509, with lytic activity against clinical carbapenem-resistant Klebsiella pneumoniae of the KL64 capsular type.
Li M; Xiao Y; Li P; Wang Z; Qi W; Qi Z; Chen L; Du H; Zhang W
Arch Virol; 2020 Dec; 165(12):2799-2806. PubMed ID: 32989574
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.
Cao F; Wang X; Wang L; Li Z; Che J; Wang L; Li X; Cao Z; Zhang J; Jin L; Xu Y
Biomed Res Int; 2015; 2015():752930. PubMed ID: 25879036
[TBL] [Abstract][Full Text] [Related]
8. Characterization and genome analysis of novel Klebsiella phage BUCT556A with lytic activity against carbapenemase-producing Klebsiella pneumoniae.
Feng J; Gao L; Li L; Zhang Z; Wu C; Li F; Tong Y
Virus Res; 2021 Oct; 303():198506. PubMed ID: 34271040
[TBL] [Abstract][Full Text] [Related]
9. Lytic Phages against ST11 K47 Carbapenem-Resistant Klebsiella pneumoniae and the Corresponding Phage Resistance Mechanisms.
Fang Q; Zong Z
mSphere; 2022 Apr; 7(2):e0008022. PubMed ID: 35255715
[TBL] [Abstract][Full Text] [Related]
10. Isolation and Characterization of vB_kpnM_17-11, a Novel Phage Efficient Against Carbapenem-Resistant
Bai J; Zhang F; Liang S; Chen Q; Wang W; Wang Y; Martín-Rodríguez AJ; Sjöling Å; Hu R; Zhou Y
Front Cell Infect Microbiol; 2022; 12():897531. PubMed ID: 35865823
[TBL] [Abstract][Full Text] [Related]
11. Potential of a Bacteriophage Isolated from Wastewater in Treatment of Lobar Pneumonia Infection Induced by Klebsiella pneumoniae in Mice.
Soleimani Sasani M; Eftekhar F
Curr Microbiol; 2020 Oct; 77(10):2650-2655. PubMed ID: 32451685
[TBL] [Abstract][Full Text] [Related]
12. Characterization and genome sequencing of a novel T7-like lytic phage, kpssk3, infecting carbapenem-resistant Klebsiella pneumoniae.
Shi Y; Chen Y; Yang Z; Zhang Y; You B; Liu X; Chen P; Liu M; Zhang C; Luo X; Chen Y; Yuan Z; Chen J; Gong Y; Peng Y
Arch Virol; 2020 Jan; 165(1):97-104. PubMed ID: 31734749
[TBL] [Abstract][Full Text] [Related]
13. ISOLATION AND CHARACTERIZATION OF BACTERIOPHAGE WITH LYTIC ACTIVITY AGAINST CARBAPENEM RESISTANCE STRAIN OF KLEBSIELLA PNEUMONIA.
Baqer AA; Nor NSM; Alagely HS; Musa M; Adnan NA
Pol Merkur Lekarski; 2023; 51(1):35-41. PubMed ID: 36960898
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage Treatment Rescues Mice Infected with Multidrug-Resistant Klebsiella pneumoniae ST258.
Hesse S; Malachowa N; Porter AR; Freedman B; Kobayashi SD; Gardner DJ; Scott DP; Adhya S; DeLeo FR
mBio; 2021 Feb; 12(1):. PubMed ID: 33622728
[TBL] [Abstract][Full Text] [Related]
15. Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates.
Horváth M; Kovács T; Koderivalappil S; Ábrahám H; Rákhely G; Schneider G
Sci Rep; 2020 Apr; 10(1):5891. PubMed ID: 32246126
[TBL] [Abstract][Full Text] [Related]
16. Characterization of bacteriophage BUCT631 lytic for K1 Klebsiella pneumoniae and its therapeutic efficacy in Galleria mellonella larvae.
Han P; Pu M; Li Y; Fan H; Tong Y
Virol Sin; 2023 Oct; 38(5):801-812. PubMed ID: 37419417
[TBL] [Abstract][Full Text] [Related]
17. Analysis of a new phage, KZag1, infecting biofilm of Klebsiella pneumoniae: genome sequence and characterization.
Saqr E; Sadik MW; El-Didamony G; Askora A
BMC Microbiol; 2024 Jun; 24(1):211. PubMed ID: 38877452
[TBL] [Abstract][Full Text] [Related]
18. Bacteriophage in the treatment of experimental septicemic mice from a clinical isolate of multidrug resistant Klebsiella pneumoniae.
Vinodkumar CS; Neelagund YF; Kalsurmath S
J Commun Dis; 2005 Mar; 37(1):18-29. PubMed ID: 16637396
[TBL] [Abstract][Full Text] [Related]
19. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation.
Zurabov F; Zhilenkov E
Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669
[TBL] [Abstract][Full Text] [Related]
20. Identification and complete genome of lytic "Kp34likevirus" phage vB_KpnP_Bp5 and therapeutic potency in the treatment of lethal Klebsiella pneumoniae infections in mice.
Zhang C; Yuan J; Guo C; Ge C; Wang X; Wei D; Li X; Si H; Hu C
Virus Res; 2021 May; 297():198348. PubMed ID: 33631221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
